These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30094402)

  • 1. L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis.
    Ohara M; Ogawa K; Suda G; Kimura M; Maehara O; Shimazaki T; Suzuki K; Nakamura A; Umemura M; Izumi T; Kawagishi N; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ohnishi S; Sakamoto N
    Hepatol Commun; 2018 Aug; 2(8):906-918. PubMed ID: 30094402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
    Hiraoka A; Kiguchi D; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):878-884. PubMed ID: 31150367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis.
    Okubo H; Ando H; Nakadera E; Ikejima K; Shiina S; Nagahara A
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis.
    Fujita M; Abe K; Hayashi M; Takahashi A; Ohira H
    Medicine (Baltimore); 2020 Jul; 99(28):e21061. PubMed ID: 32664122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.
    Hiramatsu A; Aikata H; Uchikawa S; Ohya K; Kodama K; Nishida Y; Daijo K; Osawa M; Teraoka Y; Honda F; Inagaki Y; Morio K; Morio R; Fujino H; Nakahara T; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Imamura M; Tanaka J; Chayama K
    Hepatol Commun; 2019 Mar; 3(3):348-355. PubMed ID: 30859147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia impairs prognosis of patients with liver cirrhosis.
    Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
    Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of l-carnitine supplementation in patients with cirrhosis.
    Miwa T; Hanai T; Nishimura K; Sakai Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1326-1334. PubMed ID: 35511698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levocarnitine administration in patients with chronic liver disease.
    Ohashi K; Ishikawa T; Hoshii A; Hokari T; Suzuki M; Noguchi H; Hirosawa H; Koyama F; Kobayashi M; Hirosawa S; Sugiyama K; Mitobe Y; Yoshida T
    Exp Ther Med; 2020 Nov; 20(5):94. PubMed ID: 32973943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutraceuticals for the treatment of sarcopenia in chronic liver disease.
    Hey P; Gow P; Testro AG; Apostolov R; Chapman B; Sinclair M
    Clin Nutr ESPEN; 2021 Feb; 41():13-22. PubMed ID: 33487256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.
    Davuluri G; Krokowski D; Guan BJ; Kumar A; Thapaliya S; Singh D; Hatzoglou M; Dasarathy S
    J Hepatol; 2016 Nov; 65(5):929-937. PubMed ID: 27318325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis.
    Tajiri K; Futsukaichi Y; Kobayashi S; Yasumura S; Takahara T; Minemura M; Sugiyama T
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):321-328. PubMed ID: 30381621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.
    Kitajima Y; Takahashi H; Akiyama T; Murayama K; Iwane S; Kuwashiro T; Tanaka K; Kawazoe S; Ono N; Eguchi T; Anzai K; Eguchi Y
    J Gastroenterol; 2018 Mar; 53(3):427-437. PubMed ID: 28741271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib Might Induce Sarcopenia in Patients With Hepatocellular Carcinoma by Inhibiting Carnitine Absorption.
    Amanuma M; Nagai H; Igarashi Y
    Anticancer Res; 2020 Jul; 40(7):4173-4182. PubMed ID: 32620667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function.
    Sawicka AK; Hartmane D; Lipinska P; Wojtowicz E; Lysiak-Szydlowska W; Olek RA
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29473908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine.
    Owen KQ; Jit H; Maxwell CV; Nelssen JL; Goodband RD; Tokach MD; Tremblay GC; Koo SI
    J Anim Sci; 2001 Dec; 79(12):3104-12. PubMed ID: 11811466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study.
    Evans M; Guthrie N; Pezzullo J; Sanli T; Fielding RA; Bellamine A
    Nutr Metab (Lond); 2017; 14():7. PubMed ID: 28115977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.
    Tsien C; Davuluri G; Singh D; Allawy A; Ten Have GA; Thapaliya S; Schulze JM; Barnes D; McCullough AJ; Engelen MP; Deutz NE; Dasarathy S
    Hepatology; 2015 Jun; 61(6):2018-29. PubMed ID: 25613922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Kumar A; Davuluri G; Silva RNE; Engelen MPKJ; Ten Have GAM; Prayson R; Deutz NEP; Dasarathy S
    Hepatology; 2017 Jun; 65(6):2045-2058. PubMed ID: 28195332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.